Companies Dominating the Cysteine Landscape
- Wacker Chemie AG
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Nippon Rika Kogyosho CO., LTD.
- Ajinomoto Co., Inc.
- Wuxi Bikang Bioengineering Co., Ltd
- Merck KGaA
- Croda International plc
- SERVA Electrophoresis GmbH
- Chemyunion Inc.
- Asiamerica Group, Inc.
- Exela Pharma Sciences, LLC
Browse Key Market Insights with Data Illustration:
In the News
-
Exela Pharma Sciences, LLC, a leading healthcare products provider, today announced the launch of ELCYS (cysteine hydrochloride injection), the only FDA-approved cysteine hydrochloride injection available in the United States market.
-
Wacker Chemie AG, the life science division of the WACKER group, has started the production line for cysteine in Spain. The new site aims to produce cysteine resulting from fermentation to meet growing global customer demand.
